![logo](/logos/LDX.AX.webp)
Lumos Diagnostics Holdings Limited
ASX:LDX.AX
0.04 (AUD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Lumos Diagnostics Holdings Limited |
Symbool | LDX.AX |
Munteenheid | AUD |
Prijs | 0.042 |
Beurswaarde | 20,214,894 |
Dividendpercentage | 0% |
52-weken bereik | 0.028 - 0.12 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Douglas Ward |
Website | https://lumosdiagnostics.com |
An error occurred while fetching data.
Over Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)